Telix Pharmaceuticals Limited
ACN 616 620 369
Registered Office
55 Flemington Road North Melbourne, VIC 3051
www.telixpharma.com
Share Registry
Shareholder information in relation to shareholding or share transfer can be obtained by contacting the Company’s share registry:
Link Market Services Locked Bag A14
Sydney South NSW 1235
Tel: 1300 554 474
Fax: (02) 9287 0303
Email: registrars@linkmarketservices.com.au
www.linkmarketservices.com.au
For all correspondence to the share registry, please provide your Security-holder Reference Number (SRN) or Holder Identification Number (HIN).
Change of address
Changes to your address can be updated online at www.linkmarketservices.com.au or by obtaining a Change of Address Form from the Company’s share registry. CHESS sponsored investors must change their address details via their broker.
Annual General Meeting
The Annual General Meeting will be held on Wednesday 22 May 2024. Details of how to participate will be included in the Notice of Meeting lodged with the ASX and distributed to shareholders.
Annual report mailing list
All shareholders are entitled to receive the Annual Report. In addition, shareholders may nominate not to receive an annual report by advising the share registry in writing, by fax, or by email, quoting their SRN/HIN.
Securities exchange listing
Telix Pharmaceuticals Limited's shares are listed on the Australian Securities Exchange and trade under the ASX code TLX. The securities of the Company are traded on the ASX under CHESS (Clearing House Electronic Sub-register System).
ASX shareholder disclosures
The following additional information is required by the Australian Securities Exchange in respect of listed public companies. The information is current as at 24 January 2024.
Total securities on issue
Securities (Listed) | Securities (Unlisted) | |
|---|---|---|
Fully paid ordinary shares | 323,957,272 | - |
Options to acquire shares | - | 11,752,505 |
Distribution of equity securities – ordinary shares
Range | Securities | % | No. of holders | % | |
|---|---|---|---|---|---|
100,001 and Over | 274,317,062 | 84.68 | 167 | 1.35 | |
10,001 to 100,000 | 30,193,558 | 9.32 | 1,059 | 8.58 | |
5,001 to 10,000 | 7,206,706 | 2.22 | 943 | 7.64 | |
1,001 to 5,000 | 9,605,704 | 2.97 | 3,805 | 30.83 | |
1 to 1,000 | 2,634,242 | 0.81 | 6,368 | 51.60 | |
Total | 323,957,272 | 100.00 | 12,342 | 100.00 | |
Unmarketable Parcels | - | 0.00 | - | 0.00 | |
Voting rights
Shareholders in Telix Pharmaceuticals Limited have a right to attend and vote at general meetings. At a general meeting, individual shareholders may vote in person or by proxy. A copy of the Constitution is available at https://telixpharma.com/investors/#corporate-governance. Shareholders who have a voting right percentage of greater than 5% are outlined below:
Name | Securities | % |
|---|---|---|
HSBC Custody Nominees (Australia) Limited | 38,850,342 | 11.99 |
J P Morgan Nominees Australia Pty Limited | 34,966,849 | 10.79 |
Citicorp Nominees Pty Limited | 29,118,387 | 8.99 |
Gnosis Verwaltungsgesellschaftm B H | 22,675,000 | 7.00 |
Elk River Holdings Pty Ltd As Trustee For The Behrenbruch Family Trust and C Behrenbruch | 22,675,000 | 7.00 |
Share buy-back
There is no current or planned buy-back of the Company’s shares.
Statement in accordance with ASX Listing Rule 4.10.19
The Company confirms that it has used the cash and assets in a form readily convertible to cash at the time of admission in a way consistent with its business objectives.
Twenty largest shareholders - ordinary shares
Rank | Name | 24 Jan 2024 | % |
|---|---|---|---|
1 | HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED | 38,850,342 | 11.99 |
2 | J P MORGAN NOMINEES AUSTRALIA PTY LIMITED | 34,966,849 | 10.79 |
3 | CITICORP NOMINEES PTY LIMITED | 29,118,387 | 8.99 |
4 | GNOSIS VERWALTUNGSGESELLSCHAFTM B H | 22,675,000 | 7.00 |
4 | ELK RIVER HOLDINGS PTY LTD AS TRUSTEE FOR THE BEHRENBRUCH FAMILY TRUST AND C BEHRENBRUCH | 22,675,000 | 7.00 |
5 | NATIONAL NOMINEES LIMITED | 11,451,177 | 3.53 |
6 | GRAND DECADE DEVELOPMENTS LIMITED | 10,947,181 | 3.38 |
7 | UV-CAP GMBH & CO KG | 7,454,500 | 2.30 |
8 | BNP PARIBAS NOMINEES PTY LTD ACF CLEARSTREAM | 6,623,660 | 2.04 |
9 | BNP PARIBAS NOMS PTY LTD | 6,279,603 | 1.94 |
10 | BNP PARIBAS NOMINEES PTY LTD | 5,978,960 | 1.85 |
11 | THE ONCIDIUM FOUNDATION | 5,929,331 | 1.83 |
12 | HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED - A/C 2 | 4,017,015 | 1.24 |
13 | LIGHTPOINT MEDICAL LTD | 3,298,073 | 1.02 |
14 | MAN HOLDINGS PTY LTD | 3,228,750 | 1.00 |
15 | BNP PARIBAS NOMINEES PTY LTD | 2,922,383 | 0.90 |
16 | PACIFIC CUSTODIANS PTY LIMITED | 1,990,000 | 0.61 |
17 | YELWAC PTY LTD | 1,981,804 | 0.61 |
18 | NETWEALTH INVESTMENTS LIMITED | 1,943,357 | 0.60 |
19 | UBS NOMINEES PTY LTD | 1,838,727 | 0.57 |
20 | AGLUB HOLDINGS PTY LTD | 1,733,342 | 0.54 |
Total | 225,903,441 | 69.73 | |
Balance of register | 98,053,831 | 30.27 | |
Grand total | 323,957,272 | 100.00 |